Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
Market Cap$11.29B
Close$
$106.96
78.9% upside
Current Fair Value
78.9% upsideUndervalued by 78.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.29 Billion |
|---|---|
| Enterprise Value | $10.83 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.13 |
| Beta | 0.27 |
| Outstanding Shares | 190,967,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.46 |
|---|---|
| PEG | 19.61 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 1.99 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | 0.09 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biomarin Pharmaceutical Inc.
CEO: Jean-Jacques Bienaime